株探米国株
英語
エドガーで原本を確認する
false 0001288855 0001288855 2025-07-01 2025-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) July 1, 2025

 

OPTIMUMBANK HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Florida   001-42447   55-0865043

(State or other jurisdiction

of incorporation)

 

(Commission

file number)

 

(IRS employer

identification no.)

         
2929 East Commercial Boulevard       33308
Ft. Lauderdale, Florida       (Zip Code)
(Address of principal executive offices)        

 

(954) 776-2332

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities Registered pursuant to Section 12(b) of the Act:
 
Title of each class registered   Trading Symbol(s)   Name of exchange on which registered
Common Stock   OPHC   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1933 (§240.12b-2 of this chapter)

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On July 1, 2025, OptimumBank Holdings, Inc. (the “Company”) entered into Amendment No. 1 to At Market Issuance Sales Agreement (the “Amendment”) with Compass Point Research & Trading, LLC. The Amendment amends that certain At Market Issuance Sales Agreement dated August 9, 2024 (the “Agreement”) by adding A.G.P./Alliance Global Partners to the group of Agents (as defined in the Amendment).

 

Contemporaneously with entering into the Amendment, the Company filed with the Securities and Exchange Commission (the “SEC”), pursuant to Rule 424(b)(5), a Prospectus Supplement No. 1 (the “Supplement”) to the Company’s prospectus dated August 20, 2024. The Supplement discloses the addition of A.G.P. / Alliance Global Partners as an Agent.

 

The offering of the shares pursuant to the Agreement and the Amendment is made pursuant to the Company’s registration statement on Form S-3 (File No. 333-281430), filed by the Company with the SEC on August 9, 2024, the prospectus dated August 20, 2024, and the Supplement filed by the Company with the SEC on July 1, 2025.

 

The foregoing summary of the Amendment is qualified by reference to its full text, a copy of which is filed as Exhibit 1.1 to this Form 8-K and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number  

 

Exhibit Name

  Filed Herewith
1.1   Amendment No. 1 to At Market Issuance Sales Agreement with Compass Point Research & Trading LLC and A.G.P./Alliance Global Partners, dated July 1, 2025 (Exhibit 2 has been redacted)   *
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)   *

 

The information in this report (including the exhibits) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

OPTIMUMBANK HOLDINGS, INC.  
     
Date: July 1, 2025  
     
By: /s/ Moishe Gubin  
  Moishe Gubin  
  Chairman of the Board of Directors  

 

 

EX-1.1 2 ex1-1.htm EX-1.1

 

Exhibit 1.1

 

[Individuals’ names and contact information have been redacted from Schedule 2, because they are not material to an understanding of this agreement and are typically treated as confidential by the parties.]

 

AMENDMENT NO. 1 TO AT MARKET ISSUANCE SALES AGREEMENT

 

JULY 1, 2025

 

Compass Point Research & Trading, LLC

1055 Thomas Jefferson Street, N.W.

Suite 303

Washington, DC 20007

 

A.G.P./Alliance Global Partners

590 Madison Avenue

New York, NY 10022

 

Ladies and Gentlemen:

 

OptimumBank Holdings, Inc., a Florida corporation (the “Company”) and Compass Point Research & Trading, LLC (the “Agent”) are parties to that certain At Market Issuance Sales Agreement dated August 9, 2024 (the “Original Agreement”). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The Company and the Agent desire to amend the Original Agreement as set forth in this Amendment No. 1 thereto (this “Amendment”) as follows:

 

1. The definition of “Agent” in the first paragraph of the Original Agreement is hereby amended to include A.G.P./Alliance Global Partners.

 

2. Section 14 of the Original Agreement hereby amended to include the following immediately after the contact information for Compass Point Research & Trading, LLC:

 

“and

 

A.G.P./Alliance Global Partners

590 Madison Avenue

New York, NY 10022

Attention: [redacted]

Email: [redacted]”

 

3. Schedules 1 and 2 of the Original Agreement and the Form of Representation Date Certificate Pursuant to Section 7(l) of the Original Agreement shall be replaced in their entirety with the versions attached hereto.

 

4. From and after the date hereof, the terms “Agent” as used in the Original Agreement and this Amendment shall also include the plural, “Agents” and A.G.P./Alliance Global Partners shall be considered to be an Agent under the Original Agreement, as amended hereby, and agrees to be bound by the terms of the Original Agreement, as amended hereby.

 

5. Except as specifically set forth herein, all other provisions of the Original Agreement shall remain in full force and effect.

 

 

 

6. This Amendment together with the Original Agreement (including all exhibits attached hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Amendment nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agents. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Amendment. All references in the Original Agreement to the “Agreement” shall mean the Original Agreement as amended by this Amendment; provided, however, that all references to “date of this Agreement” in the Original Agreement shall continue to refer to the date of the Original Agreement.

 

7. This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed amendment by one party to the other may be made by facsimile transmission or electronic transmission (e.g., PDF).

 

[Remainder of Page Intentionally Blank]

 

 

 

If the foregoing correctly sets forth the understanding between the Company and the Agents, please so indicate in the space provided below for that purpose, whereupon this Amendment shall constitute a binding amendment to the Original Agreement between the Company and the Agents.

 

Very truly yours,

 

OPTIMUMBANK HOLDINGS, INC.
     
  By: /s/ Moishe Gubin
  Name: Moishe Gubin
  Title: Chairman

 

COMPASS POINT RESEARCH & TRADING, LLC
     
  By: /s/ Christopher Nealon
  Name: Christopher Nealon
  Title: President & Chief Operating Officer

 

A.G.P./ALLIANCE GLOBAL PARTNERS
     
  By: /s/ Thomas J. Higgins
  Name: Thomas J. Higgins
  Title: Managing Director

 

[Signature Page to Amendment No. 1 to At Market Issuance Sales Agreement]

 

 

 

SCHEDULE 1

 

FORM OF PLACEMENT NOTICE

 

From: OPTIMUMBANK HOLDINGS, INC.
   
To: [Compass Point Research & Trading, LLC.] [A.G.P./Alliance Global Partners]
   
Attention: [●]
   
Subject: At Market Issuance—Placement Notice
   
Date: [●]

 

Gentlemen:

 

Pursuant to the terms and subject to the conditions contained in the At Market Issuance Sales Agreement, dated August 9, 2024 as amended by Amendment No. 1 dated July 1, 2025 (together, the “Agreement”), by and among OptimumBank Holdings, Inc., a Florida corporation (the “Company”), Compass Point Research & Trading, LLC, and A.G.P./Alliance Global Partners, the Company hereby requests that [identify designated Agent] sell up to ____ shares of the Company’s Common Stock during the time period beginning on [month, day, time] and ending on [month, day, time].

 

 

 

SCHEDULE 2

 

 

 

Notice Parties

 

 

 

OptimumBank Holdings, Inc.  
Attention: [redacted]  
   
Compass Point Research & Trading, LLC  
Attention: [redacted]  
   
A.G.P./Alliance Global Partners  
Attention: [redacted]  

 

 

 

EXHIBIT 7(l)

 

Form of Representation Date Certificate

 

___________, 20___

 

This Representation Date Certificate (this “Certificate”) is executed and delivered in connection with Section 7(l) of the At Market Issuance Sales Agreement, dated August 9, 2024 as amended by Amendment No. 1, dated July 1, 2025 (together, the “Agreement”), among OptimumBank Holdings, Inc., a Florida (the “Company”), Compass Point Research & Trading, LLC, and A.G.P./Alliance Global Partners (each of Compass Point Research & Trading, LLC and A.G.P./Alliance Global Partners individually an “Agent” and together, the “Agents”). All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.

 

The undersigned, a duly appointed and authorized officer of the Company, having made reasonably inquiries to establish the accuracy of the statements below and having been authorized by the Company to execute this certificate on behalf of the Company, hereby certifies as follows:

 

1. As of the date of this Certificate, (i) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading (ii) neither the Registration Statement nor the Prospectus contains any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, and (iii) no event has occurred as a result of which it is necessary to amend or supplement the Prospectus in order to make this paragraph 1 to be true.

 

2. Each of the representations and warranties of the Company contained in the Agreement were, when originally made, and are, as of the date of this Certificate, except for those representations and warranties that speak solely as of a specific date, true and correct in all material respects.

 

3. Except as waived by the Agents in writing, each of the covenants required to be performed by the Company in the Agreement on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement, has been duly, timely and fully performed in all material respects and each condition required to be complied with by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement has been duly, timely and fully complied with in all material respects.

 

4. Subsequent to the date of the most recent financial statements in the Prospectus, and except as described in the Prospectus, including in the Incorporated Documents, there has been no Material Adverse Effect.

 

6. No order suspending the effectiveness of the Registration Statement or the qualification or registration of the Placement Shares under the securities or blue sky laws of any jurisdiction are in effect and no proceeding for such purpose is pending before, or threatened, to the Company’s knowledge or in writing by, any securities or other governmental authority (including, without limitation, the Commission).

 

 

 

The undersigned has executed this Representation Date Certificate as of the date first written above.

 

OPTIMUMBANK HOLDINGS, INC.
                    
  By:  
  Name:  
  Title: